Various IGF-binding proteins in ALS patients are elevated, while IGF-1 circulating levels are reduced, suggesting that in these patients, the peripheral IGF-1 system plays an important role [108]. This evidence concerns the gene IGF1 and amyotrophic lateral sclerosis.